Happiness Biotech Group Ltd. (HAPP)
Stock Price:
$2.69 USD
0.01 (0.37%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
After-hours: $2.71 +0.02 (0.74%) Jul 10, 7:44 PM
Key Info
| Market Cap |
67.25M |
| Revenue (ttm) |
63.86M |
| Net Income (ttm) |
18.72M |
| Shares Out |
25.00M |
| EPS (ttm) |
0.80 |
| PE Ratio |
3.36 |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 10, 2020 |
| Last Price |
$2.69 |
| Previous Close |
$2.68 |
| Change ($) |
0.01 |
| Change (%) |
0.37% |
| Day's Open |
2.69 |
| Day's Range |
2.66 - 2.75 |
| Day's Volume |
335,027 |
| 52-Week Range |
2.44 - 6.10 |
More Stats
| Market Cap |
67.25M |
| Enterprise Value |
53.49M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
25.00M |
| Float |
8.49M |
| EPS (basic) |
0.81 |
| EPS (diluted) |
0.80 |
| FCF / Share |
0.27 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
29.74% |
| FCF Yield |
9.32% |
| Payout Ratio |
n/a |
| Shares Short |
68,552 |
| Short Ratio |
0.18 |
| Short % of Float |
0.74% |
| Beta |
n/a |
| PE Ratio |
3.36 |
| Forward PE |
n/a |
| P/FCF Ratio |
10.73 |
| PS Ratio |
1.05 |
| PB Ratio |
1.05 |
| Revenue |
63.86M |
| Operating Income |
21.84M |
| Net Income |
18.72M |
| Free Cash Flow |
6.27M |
| Net Cash |
13.76M |
| Net Cash / Share |
0.55 |
| Gross Margin |
50.50% |
| Operating Margin |
34.20% |
| Profit Margin |
29.30% |
| FCF Margin |
9.81% |
| ROA |
21.18% |
| ROE |
31.61% |
| ROIC |
53.20% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
10.5
Current: 2.69
High
10.5
Target: 10.50
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2018 | 2017 | 2016 |
|---|
| Revenue | 63.94 | 61.50 | 53.00 |
| Revenue Growth | 3.97% | 16.04% | - |
| Gross Profit | 32.25 | 29.35 | 25.82 |
| Operating Income | 21.84 | 20.24 | 17.21 |
| Net Income | 18.72 | 17.49 | 14.52 |
| Shares Outstanding | 23.00 | 23.00 | 23.00 |
| Earnings Per Share | 0.81 | 0.76 | 0.63 |
| EPS Growth | 6.58% | 20.63% | - |
| Operating Cash Flow | 6.54 | 12.93 | 11.32 |
| Capital Expenditures | -0.28 | -0.16 | -1.10 |
| Free Cash Flow | 6.27 | 12.78 | 10.22 |
| Cash & Equivalents | 14.80 | 8.88 | 4.27 |
| Total Debt | 1.04 | 1.49 | 1.95 |
| Net Cash / Debt | 13.76 | 7.39 | 2.32 |
| Assets | 65.68 | 53.40 | 41.53 |
| Liabilities | 4.76 | 8.84 | 18.21 |
| Book Value | 60.92 | 44.55 | 23.31 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Happiness Biotech Group Ltd. |
| Country |
China |
| CEO |
Xue Zhu Wang |
Stock Information
| Ticker Symbol |
HAPP |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Drug Manufacturers—Specialty & Generic |
| Unique Identifier |
NASDAQ: HAPP |
Description
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplements products made of Lucidum spore powder and others in the People's Republic of China. It also offers edible fungi. In addition, the company produces disinfectant products. The company was founded in 2004 and is based in Nanping, China.